Walleye Trading’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Walleye Trading’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-79,480	Closed	-$803K	–	5685
2022 Q4	$803K	Hold	79,480	–	–	﹤0.01%	2419
2022 Q3	$788K	Hold	79,480	–	–	﹤0.01%	2458
2022 Q2	$787K	Hold	79,480	–	–	﹤0.01%	2467
2022 Q1	$784K	Hold	79,480	–	–	﹤0.01%	2460
2021 Q4	$782K	Buy	+79,480	New	+$780K	﹤0.01%	2477

Walleye Trading's BIOT Position: Q1 2023 in Review

Walleye Trading sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 79,480 shares — an estimated $803K sold.

Walleye Trading first reported a position in BIOT in Q4 2021 and held it in 5 quarters. The position peaked at $803K in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

Walleye Trading reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Walleye Trading sold 79,480 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $803K.
Walleye Trading first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q4 2021 and held it in 5 quarters.
Walleye Trading's Biotech Acquisition Company Class A Ordinary Shares position peaked at $803K in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.